Penumbra, Inc Debt Securities, Available-for-sale, Amortized Cost
Penumbra, Inc (PEN) had Debt Securities, Available-for-sale, Amortized Cost of $454.78 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-07-30
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $454.78M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $375.37M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $357.81M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $149.47M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $454.78M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $375.37M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $357.81M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $149.47M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.80M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $2.81M 10-Q · filed 2025-04-23 |
| 2024-12-31 | $15.74M 10-K · filed 2026-02-25 |
| 2024-09-30 | $10.56M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $51.55M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $90.73M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $122.26M 10-K · filed 2025-02-18 |
| 2023-09-30 | $149.41M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $108.91M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $107.05M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $121.67M 10-K · filed 2024-02-22 |
| 2022-09-30 | $133.89M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $150.06M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $175.25M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $196.09M 10-K · filed 2023-02-23 |
| 2021-09-30 | $200.38M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $156.38M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $186.49M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $194.32M 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |